Corpus callosum volume in railroad workers with chronic exposure to solvents

Journal of Occupational and Environmental Medicine

Volumn 48, Issue 6, 2006, Pages 615-624

  Haut, Marc W ^a   Kuwabara, Hiroto ^b   Ducatman, Alan M ^a   Hatfield, Ginger ^a   Parsons, Michael W ^a   Scott, Allene ^c   Parsons, Elizabeth ^a   Morrow, Lisa A ^d  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UnumProvident Corporation   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOLVENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS CALLOSUM; HUMAN; LONG TERM EXPOSURE; OCCUPATIONAL EXPOSURE; RAILWAY EMPLOYEE; SAFETY; TASK PERFORMANCE; WHITE MATTER;

BRAIN DISEASES; COGNITION; CORPUS CALLOSUM; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; OCCUPATIONAL EXPOSURE; RAILROADS; SOLVENTS;

EID: 33745193940     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jom.0000205211.67120.23     Document Type: Article

References (43)

1. Morrow L, Muldoon SB, Sandstrom DJ. Neuropsychological sequelae associated with occupational and environmental exposure to chemicals. In: Tarter R, Butters M, Beers S, eds. Medical Neuropsychology: The Impact of Disease on Behavior, 2nd ed. New York: Kluwer Academic/ Plenum Publishers; 2001:199-245.
2. Morrow LA, Ryan C, Hodgson M, et al. Risk factors associated with persistence of neuropsychological deficits in persons with organic solvent exposure. J Nerv Ment Dis. 1991;179:540-545.
3. Morrow LA, Steinhauer SR, Condray R. Predictors of improvement in P300 latency in solvent exposed adults. Neuropsychiatry Neuropsychol Behav Neurol. 1998;11:146-150.
4. Kaukiainen A, Riala R, Martikainen R, et al. Solvent-related health effects among construction painters with decreasing exposure. Am J Ind Med. 2004;46:627-636.
5. Bianchini KJ, Houston RJ, Greve KW, et al. Malingered neurocognitive dysfunction in neurotoxic exposure: an application of the Slick criteria. J Occup Environ Med. 2003;45:1087-1099.
6. Schottenfeld RS, Cullen MR. Organic affective illness associated with lead intoxication. Am J Psychiatry. 1984;41: 1423-1426.
7. Morrow LA, Ryan CM, Hodgson M, Robin N. Alterations in cognitive and psychological functioning after organic solvent exposure. J Occup Med. 1990;32: 444-450.
8. Aydin K, Sencer S, Demir T, et al. Cranial MR findings in chronic toluene abuse by inhalation. AJNR Am J Neuroradiol. 2002;23:1173-1179.
9. Rosenberg NL, Kleinschmidt-DeMasters BK, Davis KA, et al. Toluene abuse causes diffuse central nervous system white matter changes. Ann Neurol. 1988; 23:611-614.
10. Unger E, Alexander A, Fritz T, et al. Toluene abuse: physical basis for hypointensity of the basal-ganglia on T2-weighted MR images. Radiology. 1994; 193:473-476.
11. Callender T, Morrow LA, Subramanian K, et al. Three dimensional brain metabolic imaging in patients with toxic encephalopathy. Environ Res. 1993;60: 295-319.
12. Fincher CE, Chang T-S, Harrell EH, et al. Comparison of single photon emission computed tomography findings in cases of healthy adults and solvent-exposed adults. Am J Ind Med. 1997;31:4-14.
13. Edling C, Hellman B, Arvidson B, et al. Do organic solvents induce changes in the dopaminergic system? Positron emission tomography studies of occupationally exposed subjects. Int Arch Occup Environ Health. 1997;70:180-186.
14. Haut MW, Leach S, Kuwabara H, et al. Verbal working memory and solvent exposure: a positron emission tomography study. Neuropsychology. 2000;14:551-558.
15. Morrow LA, Callender T, Lottenberg S, et al. PET and neurobehavioral evidence of tetrabromoethane encephalopathy. J Neuropsychiatry Clin Neurosci. 1990; 2:431-435.
16. Alkan A, Kutlu R, Hallac T, et al. Occupational prolonged organic solvent exposure in shoemakers: brain MR spectroscopy findings. Magn Reson Imaging. 2004;22: 707-713.
17. Keshavan MS, Diwadkar VA, Harenski K, et al. Abnormalities of the corpus callosum in first episode treatment naïve schizophrenia. J Neurol Neurosurg Psychiatry. 2002;72:757-760.
18. Villarreal G, Hamilton DA, Graham DP, et al. Reduced area of the corpus callosum in posttraumatic stress disorder. Psychiatry Res Neuroimaging. 2004;131:227-235.
19. Pfefferbaum A, Lim KO, Desmond JE, Sullivan EV. Thinning of the corpus callosum in older alcoholic men: a magnetic resonance imaging study. Alcohol Clin Exp Res. 1996;20:752-757.
20. Pfefferbaum A, Sullivan EV, Hedehus M, et al. Age-related declines in brain white matter anisotropy measured with spatially corrected echo-planar diffusion tensor imaging. Magn Reson Med. 2000; 44:259-268.
21. Frumkin H, Ducatman AM, Kirkland K. Solvent exposure in the railroad industry. J Occup Environ Med. 1997;39:926-930.
22. Morrow LA, Gibson C, Bagovich GR, et al. Increased incidence of anxiety and depressive disorders in persons with organic solvent exposure. Psychosom Med. 2000;62:746-750.
23. Blair JR, Spreen O. Predicting premorbid IQ: a revision of the National Adult Reading Test. Clin Neuropsychol. 1989;3:129-136.
24. First M, Spitzer RL, Gibbon M, Williams JBW. Computer Assisted SCID-Clinician Version (CAS-CV). Washington, DC: American Psychiatric Press; 1998.
25. Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders (Version 2.0). New York State Psychiatric Institute, Biometrics Research Department; 1996.
26. Demakis GJ. Frontal lobe damage and tests of executive processing: a meta-analysis of the category test, Stroop test, and Trail-Making test. J Clin Exp Neuropsychol. 2004;26:441-450.
27. Stuss DT, Floden D, Alexander MP, et al. Stroop performance in focal lesion patients: dissociation of processes and frontal lobe lesion location. Neuropsychologia. 2001; 39:771-786.
28. Haut MW, Kuwabara H, Leach S, Arias RG. Neural activation during performance of number-letter sequencing. Appl Neuropsychol. 2000;7:237-242.
29. Stuss DT, Alexander MP, Hamer L, et al. The effects of focal anterior and posterior brain lesions on verbal fluency. J Int Neuropsychol Soc. 1998;4:265-278.
30. Raz N, Rodrigue KM, Acker JD. Hypertension and the brain: vulnerability of the prefrontal regions and executive functions. Behav Neurosci. 2003;6:1169-1180.
31. Schmidt B, Lanuner LJ, Nilsson LG, et al. Magnetic resonance imaging of the brain in diabetes: the cardiovascular determinant of dementia (CASCADE) study. Diabetes. 2004;53:687-692.
32. Ferguson SC, Blane A, Perros P, et al. Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes. 2003;52:149-156.
33. Lacerda ACT, Brambilla P, Sassi RB, et al. Anatomical MRI study of the corpus callosum in unipolar depression. J Psychiatric Res. 2005;39:347-354.
34. Parashos IA, Tupler LA, Blitchington T, Krishnan KR. Magnetic-resonance morphometry in patients with major depression. Psychiatric Res. 1998;84:7-15.
35. Brambilla P, Nicoletti M, Sassi RB, et al. Corpus callosum signal intensity in patients with bipolar and unipolar depression. J Neurol Neurosurg Psychiatry. 2005;75:221-225.
36. Filley C, Heaton R, Rosenberg N. White matter dementia in chronic toluene abuse. Neurology. 1990;40:532-534.
37. Thuomas KA, Moller C, Odkvist LM, et al. MR imaging in solvent-induced chronic toxic encephalopathy. Acta Radiol. 1996; 37:177-179.
38. Pfefferbaum A, Sullivan EV. Microstructural but not macrostructural disruption of white matter in women with chronic alcoholism. Neuroimage. 2002;5:708-718.
39. O'Sullivan M, Summers PE, Jones DK, et al. Normal-appearing white matter in ischemic leukokraurosis: a diffusion tensor MRI study. Neurology. 2001;57:2307-2310.
40. Rovaris M, Bozzali M, Iannucci G, et al. Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study. Arch Neurol. 2002;59: 1406-1412.
41. Abe O, Masutani Y, Aoki S, et al. Topography of the human corpus callosum using diffusion tensor tractography. J Comput Assist Tomogr. 2004;28:533-539.
42. De Lacoste MC, Kirkpatrick JB, Ross ED. Topography of the human corpus callosum. J Neuropathol Exp Neurol. 1985;44:578-591.
43. Witelson SW. Hand and sex differences in the isthmus and genu of the human corpus callosum. A postmortem morphological study. Brain. 1989;112:799-783.